marketcap
Facebook
Twitter
Telegram
Fehler meldenGeschäftsbericht 2022
hinzugefügt 28.04.2023
Jounce Therapeutics Bilanz 2011-2024 | JNCE
Bilanz Jährlich Jounce Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-141 M | -81.8 M | -131 M | -33.5 M | -47.8 M | -23.5 M | -44.8 M | -45.2 M | -2.34 M | - | - | - |
Langfristige Schulden |
5.87 M | 9.99 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
4.15 M | 3.7 M | 3.27 M | 2.9 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | 13.6 M | 16.9 M | 44.8 M | 67 M | 109 M | 1.4 M | 5.59 M | - | - | - |
Kurzfristige Verbindlichkeiten |
23.6 M | 18.9 M | 19.3 M | 14.4 M | 65.5 M | 62.6 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
29.4 M | 28.9 M | 32.9 M | 31.3 M | 110 M | 130 M | 199 M | 8.12 M | 8.05 M | - | - | - |
Aufgeschobenes Einkommen |
- | - | 1.93 M | - | 55.2 M | 51.1 M | 80.5 M | - | - | - | - | - |
Gewinnrücklagen |
-293 M | -242 M | -151 M | -107 M | -164 M | -89.6 M | -73.2 M | -59.5 M | -28 M | - | - | - |
Vermögenswerte |
213 M | 253 M | 244 M | 206 M | 214 M | 297 M | 271 M | 53 M | 7.52 M | - | - | - |
Zahlungsmittel |
151 M | 95.5 M | 147 M | 53.2 M | 47.9 M | 23.6 M | 44.8 M | - | - | - | - | - |
Buchwert |
183 M | 224 M | 211 M | 175 M | 104 M | 167 M | 71.9 M | 44.9 M | -535 K | - | - | - |
Gesamtes Eigenkapital |
183 M | 224 M | 211 M | 175 M | 104 M | 167 M | -69.1 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Jounce Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | 6.93 M | - | 9.01 M | 9.99 M | 10.9 M | 11.9 M | 12.8 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | 28.7 M | - | 25.7 M | 28.9 M | 29 M | 27.7 M | 25.7 M | 32.9 M | 32.9 M | 32.9 M | 32.9 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 110 M | 110 M | 110 M | 110 M | 130 M | 130 M | 130 M | 130 M | 199 M | 199 M | 199 M | 199 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | 392 K | 1.93 M | 1.93 M | 1.93 M | 1.93 M | - | - | 64.9 M | 62.9 M | 55.2 M | 55.2 M | 55.2 M | 59 M | 51.1 M | 52 M | 69.2 M | 76.7 M | 80.5 M | 80.5 M | 80.5 M | 80.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
- | -344 M | - | -279 M | -242 M | -212 M | -182 M | -178 M | -151 M | -151 M | -151 M | -151 M | -107 M | -107 M | -107 M | -107 M | -164 M | -164 M | -164 M | -164 M | -89.6 M | -89.6 M | -89.6 M | -89.6 M | -73.2 M | -73.2 M | -73.2 M | -73.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
- | 158 M | - | 215 M | 253 M | 280 M | 306 M | 305 M | 244 M | 244 M | 244 M | 244 M | 206 M | 206 M | 206 M | 206 M | 214 M | 214 M | 214 M | 214 M | 297 M | 297 M | 297 M | 297 M | 271 M | 271 M | 271 M | 271 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
- | 77.1 M | - | 60.4 M | 95.5 M | 145 M | 141 M | 196 M | 147 M | 147 M | 147 M | 147 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 47.9 M | 47.9 M | 47.9 M | 47.9 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 45.2 M | - | - | - | 2.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
- | 129 M | - | 189 M | 224 M | 251 M | 278 M | 279 M | 211 M | 211 M | 211 M | 211 M | 175 M | 175 M | 175 M | 175 M | 104 M | 104 M | 104 M | 104 M | 167 M | 167 M | 167 M | 167 M | 71.9 M | 71.9 M | 71.9 M | 71.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
- | 129 M | 158 M | 189 M | 224 M | 251 M | 278 M | 279 M | 211 M | 211 M | 211 M | 211 M | 175 M | 175 M | 175 M | 175 M | 104 M | 104 M | 104 M | 104 M | 167 M | 167 M | 167 M | 167 M | -69.1 M | -69.1 M | -69.1 M | -69.1 M | -58.8 M | - | - | - | -28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung